A Study of Surufatinib in the Treatment of Advanced Soft Tissue Sarcoma

NCT06110650 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Soft Tissue Sarcoma Adult

Interventions

DRUG: Surufatinib

Sponsor

Fudan University